| Secondary |
| Drug Use For Unknown Indication |
28.5% |
| Product Used For Unknown Indication |
25.3% |
| Hypertension |
9.0% |
| Premedication |
4.4% |
| Breast Cancer |
4.1% |
| Anaemia |
2.8% |
| Arthralgia |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Prophylaxis |
2.5% |
| Lung Infection |
2.3% |
| Bipolar Disorder |
2.1% |
| Erysipelas |
2.1% |
| Iron Deficiency |
1.6% |
| Myocardial Infarction |
1.6% |
| Analgesic Intervention Supportive Therapy |
1.4% |
| Hiv Infection |
1.4% |
| Hypothyroidism |
1.4% |
| Iron Deficiency Anaemia |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Pain |
1.4% |
|
| Toxic Skin Eruption |
15.3% |
| Memory Impairment |
9.7% |
| Pyrexia |
8.3% |
| Renal Failure Acute |
5.6% |
| Rhabdomyolysis |
5.6% |
| Urinary Tract Infection |
5.6% |
| Metabolic Alkalosis |
4.2% |
| Neutropenia |
4.2% |
| Pancreatitis Acute |
4.2% |
| Paraesthesia |
4.2% |
| Renal Failure |
4.2% |
| Stress Cardiomyopathy |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Agranulocytosis |
2.8% |
| Haemothorax |
2.8% |
| Hyperlipasaemia |
2.8% |
| Hypertension |
2.8% |
| Liver Abscess |
2.8% |
| Melaena |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.7% |
| Product Used For Unknown Indication |
14.7% |
| Hypertension |
7.6% |
| Hiv Infection |
5.3% |
| Anaemia |
5.1% |
| Pain |
4.7% |
| Atrial Fibrillation |
3.8% |
| Prophylaxis |
3.5% |
| Type 2 Diabetes Mellitus |
2.6% |
| Depression |
2.5% |
| Osteoporosis |
2.4% |
| Ill-defined Disorder |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Unevaluable Event |
2.1% |
| Renal Transplant |
2.0% |
| Hepatitis C |
1.8% |
| Anxiety |
1.7% |
| Crohn's Disease |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Rheumatoid Arthritis |
1.6% |
|
| Thrombocytopenia |
11.3% |
| Toxic Skin Eruption |
9.5% |
| Renal Failure |
8.8% |
| Renal Failure Acute |
8.8% |
| Vomiting |
7.8% |
| Neutropenia |
6.7% |
| Pyrexia |
5.7% |
| Weight Decreased |
5.7% |
| Malaise |
3.9% |
| Pancytopenia |
3.5% |
| Somnolence |
3.5% |
| Overdose |
3.2% |
| Urinary Tract Infection |
3.2% |
| Hyponatraemia |
2.8% |
| Rectal Haemorrhage |
2.8% |
| Sepsis |
2.8% |
| Anaemia |
2.5% |
| Jaundice |
2.5% |
| Pulmonary Embolism |
2.5% |
| Rhabdomyolysis |
2.5% |
|
| Interacting |
| Parkinson's Disease |
15.0% |
| Anaemia |
10.0% |
| Atrial Fibrillation |
10.0% |
| Atrial Flutter |
10.0% |
| Deficiency Anaemia |
10.0% |
| Localised Infection |
10.0% |
| Unevaluable Event |
10.0% |
| Essential Hypertension |
5.0% |
| Hypothyroidism |
5.0% |
| Iron Deficiency Anaemia |
5.0% |
| Osteoporosis Postmenopausal |
5.0% |
| Pseudomonas Infection |
5.0% |
|
| Syncope |
33.3% |
| Osteitis |
16.7% |
| Presyncope |
16.7% |
| Subdural Haematoma |
16.7% |
| Wrong Technique In Drug Usage Process |
16.7% |
|
